BlackRock Finance, Inc. - FULCRUM THERAPEUTICS INC ownership

FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 127 filers reported holding FULCRUM THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.

Quarter-by-quarter ownership
BlackRock Finance, Inc. ownership history of FULCRUM THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$29,750,836
+104.5%
4,798,522
+211.3%
0.00%
Q1 2024$14,549,013
+38.0%
1,541,209
-1.3%
0.00%
Q4 2023$10,542,598
+64.2%
1,561,866
+8.0%
0.00%
Q3 2023$6,419,965
+28.5%
1,445,938
-4.5%
0.00%
Q2 2023$4,997,603
-58.1%
1,514,425
-63.8%
0.00%
Q1 2023$11,923,654
-49.9%
4,183,738
+28.0%
0.00%
-100.0%
Q4 2022$23,798,256
+6.1%
3,268,991
+17.9%
0.00%0.0%
Q3 2022$22,428,000
+72.5%
2,772,344
+4.4%
0.00%
Q2 2022$13,005,000
-75.3%
2,654,378
+19.1%
0.00%
-100.0%
Q1 2022$52,707,000
+34.9%
2,228,610
+0.9%
0.00%0.0%
Q4 2021$39,063,000
-31.8%
2,208,078
+8.7%
0.00%
-50.0%
Q3 2021$57,290,000
+321.3%
2,030,873
+56.5%
0.00%
Q2 2021$13,598,000
+2.3%
1,297,445
+15.0%
0.00%
Q1 2021$13,294,000
+8.8%
1,128,579
+8.2%
0.00%
Q4 2020$12,217,000
+133.7%
1,043,284
+58.3%
0.00%
Q3 2020$5,227,000
-57.4%
659,197
-1.7%
0.00%
Q2 2020$12,261,000
+65.4%
670,352
+7.9%
0.00%
Q1 2020$7,415,000
+111.8%
621,065
+195.2%
0.00%
Q4 2019$3,501,000
+457.5%
210,376
+122.4%
0.00%
Q3 2019$628,00094,6000.00%
Other shareholders
FULCRUM THERAPEUTICS INC shareholders Q2 2024
NameSharesValueWeighting ↓
TRV GP IV, LLC 2,343,154$7,732,4086.99%
SUVRETTA CAPITAL MANAGEMENT, LLC 5,718,881$18,872,3071.01%
COWEN AND COMPANY, LLC 3,116,996$10,286,0860.85%
RA Capital Management 11,609,704$38,312,0230.72%
RTW INVESTMENTS, LP 6,064,123$20,011,6060.38%
Simplify Asset Management Inc. 696,296$2,297,7770.30%
Acuitas Investments, LLC 134,815$444,8900.26%
Vivo Capital, LLC 550,000$1,815,0000.12%
Opaleye Management Inc. 143,600$473,8800.11%
HARVARD MANAGEMENT CO INC 341,972$1,1290.11%
View complete list of FULCRUM THERAPEUTICS INC shareholders